Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

The BeSt way of withdrawing biologic agents.

Allaart CF, Lems WF, Huizinga TW.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S14-8. Epub 2013 Oct 3.

PMID:
24129130
2.

Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.

Allaart CF, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Breedveld FC, Dijkmans BA; FARR study group.

Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-77-82.

PMID:
17083767
3.

Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study.

Allaart CF, Breedveld FC, Dijkmans BA.

J Rheumatol Suppl. 2007 Nov;80:25-33.

PMID:
17985420
4.

Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.

van der Kooij SM, le Cessie S, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Zeben D, Kerstens PJ, Hazes JM, van Schaardenburg D, Breedveld FC, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2009 Jul;68(7):1153-8. doi: 10.1136/ard.2008.093294. Epub 2008 Oct 17.

PMID:
18930988
5.

Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study.

van den Broek M, Klarenbeek NB, Dirven L, van Schaardenburg D, Hulsmans HM, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Aug;70(8):1389-94. doi: 10.1136/ard.2010.147751. Epub 2011 Apr 24.

PMID:
21515916
6.

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis.

van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Güler-Yüksel M, Zwinderman AH, Kerstens PJ, van der Lubbe PA, de Beus WM, Grillet BA, Ronday HK, Huizinga TW, Breedveld FC, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2009 Jun;68(6):914-21. doi: 10.1136/ard.2008.092254. Epub 2008 Jul 28.

PMID:
18662933
7.

Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis.

van der Bijl AE, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Ten Wolde S, Han KH, van Krugten MV, Allaart CF, Breedveld FC, Dijkmans BA.

Arthritis Rheum. 2007 Jul;56(7):2129-34.

8.

Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score.

van der Kooij SM, de Vries-Bouwstra JK, Goekoop-Ruiterman YP, van Zeben D, Kerstens PJ, Gerards AH, van Groenendael JH, Hazes JM, Breedveld FC, Allaart CF, Dijkmans BA.

Ann Rheum Dis. 2007 Oct;66(10):1356-62. Epub 2007 Feb 9.

9.

Discontinuation of biologics in patients with rheumatoid arthritis.

Tanaka Y, Hirata S, Saleem B, Emery P.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S22-7. Epub 2013 Oct 3. Review.

PMID:
24129132
10.

Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial.

Ferraccioli GF, Assaloni R, Di Poi E, Gremese E, De Marchi G, Fabris M.

Rheumatology (Oxford). 2002 Oct;41(10):1109-12.

11.

Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission.

Nawata M, Saito K, Nakayamada S, Tanaka Y.

Mod Rheumatol. 2008;18(5):460-4. doi: 10.1007/s10165-008-0089-1. Epub 2008 Jun 6.

PMID:
18535759
12.

Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.

Chang CY, Meyer RM, Reiff AO.

Arthritis Care Res (Hoboken). 2015 May;67(5):658-66. doi: 10.1002/acr.22477.

PMID:
25220674
13.

Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients.

Zhang J, Xie F, Delzell E, Yun H, Lewis JD, Haynes K, Chen L, Beukelman T, Saag KG, Curtis JR.

Arthritis Care Res (Hoboken). 2015 May;67(5):624-32. doi: 10.1002/acr.22510.

PMID:
25370912
14.

A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study.

Heimans L, Wevers-de Boer KV, Visser K, Goekoop RJ, van Oosterhout M, Harbers JB, Bijkerk C, Speyer I, de Buck MP, de Sonnaville PB, Grillet BA, Huizinga TW, Allaart CF.

Ann Rheum Dis. 2014 Jul;73(7):1356-61. doi: 10.1136/annrheumdis-2013-203243. Epub 2013 May 28.

PMID:
23716067
15.

Is it possible to withdraw biologics from therapy in rheumatoid arthritis?

Tanaka Y, Hirata S.

Clin Ther. 2013 Dec;35(12):2028-35. doi: 10.1016/j.clinthera.2013.10.008. Epub 2013 Nov 28. Review.

PMID:
24290736
16.

Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study).

Nam JL, Villeneuve E, Hensor EM, Conaghan PG, Keen HI, Buch MH, Gough AK, Green MJ, Helliwell PS, Keenan AM, Morgan AW, Quinn M, Reece R, van der Heijde DM, Wakefield RJ, Emery P.

Ann Rheum Dis. 2014 Jan;73(1):75-85. doi: 10.1136/annrheumdis-2013-203440. Epub 2013 Aug 2.

PMID:
23912798
17.

Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.

Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM.

Clin Ther. 2008 Nov;30(11):1939-55. doi: 10.1016/j.clinthera.2008.11.007. Review.

PMID:
19108784
18.

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

19.

Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis?

Scott IC, Kingsley GH, Scott DL.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S4-8. Epub 2013 Oct 3. Review.

PMID:
24129128
20.

Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial.

Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Peeters AJ, de Jonge-Bok JM, Mallée C, de Beus WM, de Sonnaville PB, Ewals JA, Breedveld FC, Dijkmans BA.

Ann Intern Med. 2007 Mar 20;146(6):406-15.

PMID:
17371885
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk